MedPath

UNIVERSITY OF UTAH

UNIVERSITY OF UTAH logo
🇺🇸United States
Ownership
Private
Established
1850-02-28
Employees
10K
Market Cap
-
Website
http://www.utah.edu

Impact of Glistenings in AcrySof Intraocular Lenses on Visual Quality

Completed
Conditions
Visual Quality
Lenses, Intraocular
Glistenings
First Posted Date
2010-09-16
Last Posted Date
2014-12-11
Lead Sponsor
University of Utah
Target Recruit Count
200
Registration Number
NCT01202981
Locations
🇺🇸

University of Utah, John Moran Eye Center, Salt Lake City, Utah, United States

Practice Effects and Amyloid Imaging Using 18F-PIB or Flutemetamol PET and FDG-PET

Phase 2
Completed
Conditions
Alzheimer's Disease
Interventions
Drug: 18F-Flutemetamol
First Posted Date
2010-09-16
Last Posted Date
2023-05-09
Lead Sponsor
University of Utah
Target Recruit Count
27
Registration Number
NCT01202994
Locations
🇺🇸

University of Utah Center for Alzheimer's Care, Imaging and Research, Salt Lake City, Utah, United States

Discovering the Gene(s) Causing Developmental Dysplasia of the Hip (DDH)

Completed
Conditions
Hip Dysplasia
First Posted Date
2010-09-02
Last Posted Date
2019-10-23
Lead Sponsor
University of Utah
Target Recruit Count
160
Registration Number
NCT01193673
Locations
🇺🇸

University of Utah Orthopaedic Center, Salt Lake City, Utah, United States

Genetic Factors Affecting Risks for Rotator Cuff Disease

Conditions
Studying the Genetic Relationship of Rotator Cuff Tears
First Posted Date
2010-09-02
Last Posted Date
2025-01-09
Lead Sponsor
University of Utah
Target Recruit Count
400
Registration Number
NCT01193647
Locations
🇺🇸

VA Salt Lake City, Salt Lake City, Utah, United States

🇺🇸

University of Utah Orthopaedic Center, Salt Lake City, Utah, United States

Effect of Structural Remodeling on Scar Formation as Assessed by DE-MRI of the Left Atrium

Completed
Conditions
Atrial Fibrillation
First Posted Date
2010-08-24
Last Posted Date
2012-02-13
Lead Sponsor
University of Utah
Target Recruit Count
40
Registration Number
NCT01187914

A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients

Phase 2
Completed
Conditions
Adenomatous Polyposis Coli
Interventions
Drug: Placebo A
Drug: Erlotinib
Drug: Placebo B
Drug: Sulindac
First Posted Date
2010-08-24
Last Posted Date
2016-06-17
Lead Sponsor
University of Utah
Target Recruit Count
92
Registration Number
NCT01187901
Locations
🇺🇸

Huntsman Cancer Institute, Salt Lake City, Utah, United States

SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI

Phase 3
Completed
Conditions
Atrial Fibrillation
Interventions
Drug: Placebo
Drug: dronedarone
First Posted Date
2010-08-16
Last Posted Date
2016-02-19
Lead Sponsor
University of Utah
Target Recruit Count
33
Registration Number
NCT01182376

Effects of Lovaza on High Density Lipoprotein (HDL) Composition and Function in Hypertriglyceridemia

Phase 4
Withdrawn
Conditions
Hypertriglyceridemia
Interventions
First Posted Date
2010-08-12
Last Posted Date
2016-02-08
Lead Sponsor
University of Utah
Registration Number
NCT01180764
Locations
🇺🇸

University of Utah, Salt Lake City, Utah, United States

Creatine Augmentation in Veterans With SSRI-Resistant Major Depression

Phase 4
Withdrawn
Conditions
Major Depressive Disorder
Interventions
First Posted Date
2010-08-05
Last Posted Date
2016-08-15
Lead Sponsor
University of Utah
Registration Number
NCT01175616

Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients

Not Applicable
Withdrawn
Conditions
Trauma
Pain
Interventions
First Posted Date
2010-07-23
Last Posted Date
2012-06-04
Lead Sponsor
University of Utah
Registration Number
NCT01169025
Locations
🇺🇸

University of Utah Medical Center, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath